wehewehe
Hanaʻia kā mākou 4-Chloropyrrolidine CAS No. 3680-69-1 i nā kūlanaʻoihana kiʻekiʻe loa, e hōʻoiaʻiʻo ana i ka maʻemaʻe a me ke kūpaʻa i kēlā me kēia pahu.Ma keʻano he alakaʻi alakaʻi o nā kemika maikaʻi a me nā mea waena, haʻaheo mākou iā mākou iho i ka hāʻawi ʻana i kā mākou mea kūʻai aku i nā huahana maikaʻi loa i kūpono i kā lākou kikoʻī kikoʻī a me nā koi.
ʻO 4-Chloropyrrolidine he mea nui i ka synthesis o tofacitinib, iʻikeʻia no kona pono i ka ho'ēmiʻana i ka mumū a me kaʻeha e pili ana i nā maʻi autoimmune.Ma ka hoʻohanaʻana i kā mākou mau kikowaena kiʻekiʻe, hiki i nā mea hana lāʻau lapaʻau ke hana i ka tofacitinib a me nā mea'ē aʻe e pili ana me ka hilinaʻi, me kaʻike i ka maʻemaʻe a me ka hilinaʻi o kā mākou 4-chloropyrrolidine e kōkua i ka maikaʻi o ka huahana hope loa.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
